Testing effectiveness (Phase 2)Study completedNCT03499795
What this trial is testing
VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2
Who this might be right for
Anal Neoplasm
Inovio Pharmaceuticals 23